Reactive Oxygen Species-Responsive Liposomes via Boronate-Caged Phosphatidylethanolamine

被引:25
作者
Lou, Jinchao [1 ]
Best, Michael D. [1 ]
机构
[1] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA
基金
美国国家科学基金会;
关键词
PH-SENSITIVE LIPOSOMES; DRUG-DELIVERY SYSTEMS; OF-THE-ART; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; THERAPEUTIC INDEX; RELEASE; CANCER; PHARMACOKINETICS; ROS;
D O I
10.1021/acs.bioconjchem.0c00397
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Liposomes have proven to be effective nanocarriers due to their ability to encapsulate and deliver a wide variety of therapeutic cargo. A key goal of liposome research is to enhance control over content release at diseased sites. Though a number of stimuli have been explored for triggering liposomal release, reactive oxygen species (ROS), which have received significantly less attention, provide excellent targets due to their key roles in biology and overabundance in diseased cells. Here, we report a ROS-responsive liposome platform through the inclusion of lipid 1 bearing a boronate ester headgroup and a quinone-methide (QM) generating self-immolative linker attached onto a dioleoylphosphatidylethanolamine (DOPE) lipid scaffold. Fluorescence-based dye release assays validated that this system enables release of both hydrophobic and hydrophilic contents upon hydrogen peroxide (H2O2) addition. Details of the release process were carefully studied, and data showed that oxidative removal of the boronate headgroup is sufficient to result in hydrophobic content release, while production of DOPE is needed for hydrophilic cargo leakage. These results showcase that lipid 1 can serve as a promising ROS-responsive liposomal delivery platform for controlled release.
引用
收藏
页码:2220 / 2230
页数:11
相关论文
共 63 条
[1]  
Alam S., 2017, Comprehensive Supramolecular Chemistry II, V5, P329, DOI [DOI 10.1016/B978-0-12-409547-2.12540-5, 10.1016/B978-0-12-409547-2.12540-5]
[2]   Enzyme-triggered nanomedicine: Drug release strategies in cancer therapy (Invited Review) [J].
Andresen, Thomas L. ;
Thompson, David H. ;
Kaasgaard, Thomas .
MOLECULAR MEMBRANE BIOLOGY, 2010, 27 (07) :353-363
[3]   Reactive oxygen species: Metabolism, oxidative stress, and signal transduction [J].
Apel, K ;
Hirt, H .
ANNUAL REVIEW OF PLANT BIOLOGY, 2004, 55 :373-399
[4]   DIFFUSION OF UNIVALENT IONS ACROSS LAMELLAE OF SWOLLEN PHOSPHOLIPIDS [J].
BANGHAM, AD ;
STANDISH, MM ;
WATKINS, JC .
JOURNAL OF MOLECULAR BIOLOGY, 1965, 13 (01) :238-+
[5]   Triggered Liposomal Release through a Synthetic Phosphatidylcholine Analogue Bearing a Photocleavable Moiety Embedded within the sn-2 Acyl Chain [J].
Bayer, Andrew M. ;
Alam, Shahrina ;
Mattern-Schain, Samuel I. ;
Best, Michael D. .
CHEMISTRY-A EUROPEAN JOURNAL, 2014, 20 (12) :3350-3357
[6]  
Bennett Doyle E., 1994, Journal of Liposome Research, V4, P331, DOI 10.3109/08982109409037048
[7]   Trigger release liposome systems: local and remote controlled delivery? [J].
Bibi, Sagida ;
Lattmann, E. ;
Mohammed, Afzal R. ;
Perrie, Yvonne .
JOURNAL OF MICROENCAPSULATION, 2012, 29 (03) :262-276
[8]   Strategies for triggered drug release from tumor targeted liposomes [J].
Blenke, Erik Oude ;
Mastrobattista, Enrico ;
Schiffelers, Raymond M. .
EXPERT OPINION ON DRUG DELIVERY, 2013, 10 (10) :1399-1410
[9]   Nanoparticle-Based Medicines: A Review of FDA-Approved Materials and Clinical Trials to Date [J].
Bobo, Daniel ;
Robinson, Kye J. ;
Islam, Jiaul ;
Thurecht, Kristofer J. ;
Corrie, Simon R. .
PHARMACEUTICAL RESEARCH, 2016, 33 (10) :2373-2387
[10]   The role of liposomes in clinical nanomedicine development. What now? Now what? [J].
Crommelin, Daan J. A. ;
van Hoogevest, Peter ;
Storm, Gert .
JOURNAL OF CONTROLLED RELEASE, 2020, 318 (318) :256-263